Affiliations
AffiliationItem in Clipboard
Long-term colorectal-cancer mortality after adenoma removalMagnus Løberg et al. N Engl J Med. 2014.
Free article . 2014 Aug 28;371(9):799-807. doi: 10.1056/NEJMoa1315870. AffiliationItem in Clipboard
AbstractBackground: Although colonoscopic surveillance of patients after removal of adenomas is widely promoted, little is known about colorectal-cancer mortality among these patients.
Methods: Using the linkage of the Cancer Registry and the Cause of Death Registry of Norway, we estimated colorectal-cancer mortality among patients who had undergone removal of colorectal adenomas during the period from 1993 through 2007. Patients were followed through 2011. We calculated standardized incidence-based mortality ratios (SMRs) using rates for the Norwegian population at large for comparison. Norwegian guidelines recommended colonoscopy after 10 years for patients with high-risk adenomas (adenomas with high-grade dysplasia, a villous component, or a size ≥10 mm) and after 5 years for patients with three or more adenomas; no surveillance was recommended for patients with low-risk adenomas. Polyp size and exact number were not available in the registry. We defined high-risk adenomas as multiple adenomas and adenomas with a villous component or high-grade dysplasia.
Results: We identified 40,826 patients who had had colorectal adenomas removed. During a median follow-up of 7.7 years (maximum, 19.0), 1273 patients were given a diagnosis of colorectal cancer. A total of 398 deaths from colorectal cancer were expected and 383 were observed, for an SMR of 0.96 (95% confidence interval [CI], 0.87 to 1.06) among patients who had had adenomas removed. Colorectal-cancer mortality was increased among patients with high-risk adenomas (expected deaths, 209; observed deaths, 242; SMR, 1.16; 95% CI, 1.02 to 1.31), but it was reduced among patients with low-risk adenomas (expected deaths, 189; observed deaths, 141; SMR, 0.75; 95% CI, 0.63 to 0.88).
Conclusions: After a median of 7.7 years of follow-up, colorectal-cancer mortality was lower among patients who had had low-risk adenomas removed and moderately higher among those who had had high-risk adenomas removed, as compared with the general population. (Funded by the Norwegian Cancer Society and others.).
Similar articlesEmilsson L, Løberg M, Bretthauer M, Holme Ø, Fall K, Jodal HC, Adami HO, Kalager M. Emilsson L, et al. Scand J Gastroenterol. 2017 Dec;52(12):1377-1384. doi: 10.1080/00365521.2017.1377763. Epub 2017 Sep 14. Scand J Gastroenterol. 2017. PMID: 28906163
Atkin WS, Morson BC, Cuzick J. Atkin WS, et al. N Engl J Med. 1992 Mar 5;326(10):658-62. doi: 10.1056/NEJM199203053261002. N Engl J Med. 1992. PMID: 1736104
Jodal HC, Klotz D, Herfindal M, Barua I, Tag P, Helsingen LM, Refsum E, Holme Ø, Adami HO, Bretthauer M, Kalager M, Løberg M. Jodal HC, et al. Aliment Pharmacol Ther. 2022 Feb;55(4):412-421. doi: 10.1111/apt.16686. Epub 2021 Oct 30. Aliment Pharmacol Ther. 2022. PMID: 34716941
Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK; US Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Winawer SJ, et al. Gastroenterology. 2006 May;130(6):1872-85. doi: 10.1053/j.gastro.2006.03.012. Gastroenterology. 2006. PMID: 16697750 Review.
Dubé C, Yakubu M, McCurdy BR, Lischka A, Koné A, Walker MJ, Peirson L, Tinmouth J. Dubé C, et al. Am J Gastroenterol. 2017 Dec;112(12):1790-1801. doi: 10.1038/ajg.2017.360. Epub 2017 Oct 31. Am J Gastroenterol. 2017. PMID: 29087393 Review.
Abu-Freha N, Katz LH, Kariv R, Vainer E, Laish I, Gluck N, Half EE, Levi Z. Abu-Freha N, et al. United European Gastroenterol J. 2021 Jul;9(6):681-687. doi: 10.1002/ueg2.12106. Epub 2021 Jun 2. United European Gastroenterol J. 2021. PMID: 34077635 Free PMC article. Review.
Ferreira AO, Reves JB, Nascimento C, Frias-Gomes C, Costa-Santos MP, Ramos LR, Palmela C, Gloria L, Cravo M, Dinis-Ribeiro M, Canena J. Ferreira AO, et al. GE Port J Gastroenterol. 2022 Oct 27;30(5):368-374. doi: 10.1159/000526606. eCollection 2023 Oct. GE Port J Gastroenterol. 2022. PMID: 37868631 Free PMC article.
de Groen PC, Li YJ, Xirasagar S. de Groen PC, et al. N Engl J Med. 2014 Nov 20;371(21):2035. doi: 10.1056/NEJMc1411954. N Engl J Med. 2014. PMID: 25409379 Free PMC article. No abstract available.
Kang HS, Na SY, Yoon JY, Jung Y, Seo GS, Cha JM. Kang HS, et al. J Gastroenterol. 2024 May;59(5):402-410. doi: 10.1007/s00535-024-02089-9. Epub 2024 Mar 16. J Gastroenterol. 2024. PMID: 38492010 Clinical Trial.
Bao EL, Nandakumar SK, Liao X, Bick AG, Karjalainen J, Tabaka M, Gan OI, Havulinna AS, Kiiskinen TTJ, Lareau CA, de Lapuente Portilla AL, Li B, Emdin C, Codd V, Nelson CP, Walker CJ, Churchhouse C, de la Chapelle A, Klein DE, Nilsson B, Wilson PWF, Cho K, Pyarajan S, Gaziano JM, Samani NJ; FinnGen; 23andMe Research Team; Regev A, Palotie A, Neale BM, Dick JE, Natarajan P, O'Donnell CJ, Daly MJ, Milyavsky M, Kathiresan S, Sankaran VG. Bao EL, et al. Nature. 2020 Oct;586(7831):769-775. doi: 10.1038/s41586-020-2786-7. Epub 2020 Oct 14. Nature. 2020. PMID: 33057200 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3